Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary-Progressive Multiple Sclerosis”

175 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 175 results

Testing effectiveness (Phase 2)Study completedNCT01450488
What this trial is testing

Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AB Science 35
Not applicableStudy completedNCT04593927
What this trial is testing

Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients

Who this might be right for
Secondary Progressive Multiple Sclerosis (SPMS)
Novartis Pharmaceuticals 451
Testing effectiveness (Phase 2)Ended earlyNCT03283826
What this trial is testing

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Atara Biotherapeutics 134
Not applicableEnded earlyNCT04746976
What this trial is testing

Study of Diroximel Fumarate in the Real-World Setting

Who this might be right for
Relapsing Forms of MS
Biogen 75
Not applicableStudy completedNCT01235455
What this trial is testing

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Secondary Progressive Multiple Sclerosis (SPMS)
Bayer 10
Testing effectiveness (Phase 2)Study completedNCT00228163
What this trial is testing

Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

Who this might be right for
Multiple Sclerosis
Sanofi 147
Testing effectiveness (Phase 2)UnknownNCT01228396
What this trial is testing

AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Daval International Limited 20
Early research (Phase 1)Study completedNCT00616733
What this trial is testing

12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Daiichi Sankyo 25
Large-scale testing (Phase 3)Study completedNCT00869726
What this trial is testing

Patients With Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Eli Lilly and Company 596
Large-scale testing (Phase 3)Study completedNCT00799890
What this trial is testing

Sunphenon in Progressive Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Friedemann Paul 61
Large-scale testing (Phase 3)Study completedNCT03315923
What this trial is testing

Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients

Who this might be right for
Secondary Progressive Multiple Sclerosis
Isfahan University of Medical Sciences 84
Early research (Phase 1)Study completedNCT01381354
What this trial is testing

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

Who this might be right for
Multiple Sclerosis
University of Iowa 38
Large-scale testing (Phase 3)Active Not RecruitingNCT06141486
What this trial is testing

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 943
Not applicableLooking for participantsNCT07355387
What this trial is testing

Home Based Functional Balance Intervention for Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more
University of Illinois at Chicago 75
Testing effectiveness (Phase 2)Study completedNCT02228213
What this trial is testing

Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Innate Immunotherapeutics 93
Not applicableStudy completedNCT03134573
What this trial is testing

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

Who this might be right for
Multiple Sclerosis
Bayer 96
Large-scale testing (Phase 3)Study completedNCT01433497
What this trial is testing

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapse Free
AB Science 656
Not applicableLooking for participantsNCT05204459
What this trial is testing

MS-ResearchBiomarkerS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+8 more
Cedars-Sinai Medical Center 1,000
Early research (Phase 1)Ended earlyNCT01318421
What this trial is testing

ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 12
Testing effectiveness (Phase 2)Looking for participantsNCT07477639
What this trial is testing

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis (SPMS)Multiple Sclerosis+2 more
Tr1X, Inc. 39
Next Page